APTOF · Aptose Biosciences Inc.
$1.69
+0.02 (+0.90%)
At close · Jul 2
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our ability to continue as a going concern; - our need to raise substantial additional capital in the near future and our ability to raise such funds when needed and on acceptable terms; - if a financing is completed, it may not be a large enough financing to fully fund the company's operations”View the 10-Q filed May 13, 2026
Market Cap
$4.31M
Shares
2.55M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-14 | European Hematology Association Congress (EHA 2026) | Event |
| 2026-03-31 | Special Meeting of Shareholders | Shareholder meeting |
Source: https://www.aptose.com/investors